These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19549434)

  • 1. A case of severe refractory chronic urticaria: a novel method for evaluation and treatment.
    Otto HF; Calabria CW
    Allergy Asthma Proc; 2009; 30(3):333-7. PubMed ID: 19549434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of hypersensitivity to autologous sweat and serum in cholinergic urticaria: cholinergic urticaria may have different subtypes.
    Kim JE; Jung KH; Cho HH; Kang H; Park YM; Park HJ; Lee JY
    Int J Dermatol; 2015 Jul; 54(7):771-7. PubMed ID: 25069826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab for the treatment of chronic urticaria.
    Zuberbier T; Maurer M
    Expert Rev Clin Immunol; 2015 Feb; 11(2):171-80. PubMed ID: 25566680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic autoimmune urticaria with omalizumab.
    Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic autoimmune urticaria: treatment with omalizumab].
    Máspero JF; Parisi CA; De Gennaro M; Benhabib O; Lampert M
    Arch Argent Pediatr; 2009 Oct; 107(5):452-6. PubMed ID: 19809768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
    Maurer M; Altrichter S; Bieber T; Biedermann T; Bräutigam M; Seyfried S; Brehler R; Grabbe J; Hunzelmann N; Jakob T; Jung A; Kleine-Tebbe J; Mempel M; Meurer M; Reich K; Ruëff F; Schäkel K; Sengupta K; Sieder C; Simon JC; Wedi B; Zuberbier T; Mahler V; Staubach P
    J Allergy Clin Immunol; 2011 Jul; 128(1):202-209.e5. PubMed ID: 21636116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
    Metz M; Ohanyan T; Church MK; Maurer M
    J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab therapy in three patients with chronic autoimmune urticaria.
    Al-Ahmad M
    Ann Saudi Med; 2010; 30(6):478-81. PubMed ID: 20864790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of omalizumab on patients with chronic urticaria.
    Spector SL; Tan RA
    Ann Allergy Asthma Immunol; 2007 Aug; 99(2):190-3. PubMed ID: 17718108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab in the treatment of chronic urticaria.
    Francés L; Leiva-Salinas M; Silvestre JF
    Actas Dermosifiliogr; 2014; 105(1):45-52. PubMed ID: 23938072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omalizumab in chronic urticaria: a retrospective series of 15 cases.
    Armengot-Carbo M; Velasco-Pastor M; Rodrigo-Nicolas B; Pont-Sanjuan V; Quecedo-Estebanez E; Gimeno-Carpio E
    Dermatol Ther; 2013; 26(3):257-9. PubMed ID: 23742285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with steroids and antihistaminic drug allergy and newly occurred chronic urticaria angioedema: what about omalizumab?
    Kutlu A; Karabacak E; Aydin E; Ozturk S; Bozkurt B
    Hum Exp Toxicol; 2014 Aug; 33(8):882-5. PubMed ID: 24203455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severely recalcitrant chronic spontaneous urticaria: a discussion of relevant issues.
    Wieder S; Maurer M; Lebwohl M
    Am J Clin Dermatol; 2015 Feb; 16(1):19-26. PubMed ID: 25452254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
    Song CH; Stern S; Giruparajah M; Berlin N; Sussman GL
    Ann Allergy Asthma Immunol; 2013 Feb; 110(2):113-7. PubMed ID: 23352531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of omalizumab in the treatment of chronic urticaria.
    Stitt JM; Dreskin SC
    Immunotherapy; 2014; 6(6):691-7. PubMed ID: 25186602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.
    Lang DM
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
    Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
    J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Argentine guidelines for urticaria and angioedema].
    Máspero J; Cabrera H; Ardusso L; De Gennaro M; Fernández Bussy R; Galimany J; Galimberti D; Label M; La Forgia M; Medina I; Neffen H; Troielli P; ;
    Medicina (B Aires); 2014; 74 Suppl 1():1-53. PubMed ID: 25202880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of the basophil activation test in the diagnosis of sweat allergy.
    Oda Y; Washio K; Fukunaga A; Imamura S; Hatakeyama M; Ogura K; Ishii K; Hide M; Nishigori C
    Allergol Int; 2020 Apr; 69(2):261-267. PubMed ID: 31615718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life experiences with omalizumab for the treatment of chronic urticaria.
    Sussman G; Hébert J; Barron C; Bian J; Caron-Guay RM; Laflamme S; Stern S
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):170-4. PubMed ID: 24468258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.